In a chat with ET Now, Amit Bakshi, CMD, Eris Lifescience said that the company is trying to be a significant player on therapy areas and the FCF conversion from EBITDA is very high. Edited excerpt:
For More Details Visit-
via Eris Lifesciences IPO price band will be at Rs 603: CMD Amit Bakshi
No comments:
Post a Comment